Annual Report

Overview

The report marks LLS's 75th anniversary and describes 2024 work across blood cancer research, patient support, health equity, survivorship, advocacy, and philanthropy. It highlights $332.2 million in multi-year research commitments, more than 1,500 Beat AML trial patients enrolled, and new CAR-T grants. Health-equity efforts included $14.2 million in health-services research investment, six IMPACT sites, and expanded outreach to Spanish-speaking communities. The consolidated financial statements report total revenue of 388,211 USD Thousands for the year ended June 30, 2024.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2024
Period: Ends 30 June 2024
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services